OUR AREAS OF INTEREST


Global Out-Licensing

All Therapeutic Areas

Merck has continued to prioritize its pipeline and disease areas to focus on therapeutic areas where we believe we can achieve the greatest impact. This has resulted in a significant number of compounds becoming available for out-licensing. These are at all development stages, from preclinical to Phase III from the following therapeutic areas:

Oncology Infectious Diseases
Respiratory & Inflammation Neuroscience
Ophthalmology Cardiovascular
Women's Health Diabetes & Endocrinology
Biologics

A complete list of assets (or portion thereof) is available under CDA. If there is interest in specific assets, Merck can provide a confidential presentation on each selected asset.

For further information and initial contact:

Meeta Chatterjee, PhD
Head, Global Out-Licensing & Asset Management,
Worldwide Licensing
Merck Research Laboratories
K-15; Mailstop 4385
2000 Galloping Hill Rd
Kenilworth, NJ 07033


Contact

Areas of Interest

Click on the icons below for more information about your areas of interest.

Research & Enabling Technologies Atherosclerosis and Cardiovascular Diseases Biologics Respiratory and Immunology Diabetes and Endocrinology Infectious Diseases Neurosciences and Ophthalmology Oncology Therapeutics Vaccines Global Out-Licensing

Have a Discovery?

If you think something you discovered might be of interest to Merck, contact one of our scientific scouts.

Learn more about us

TRUSTe - Click to Verify   This Web This Web Accessibility icon serves as a link to download eSSENTIAL Accessibility assistive technology software for individuals with physical disabilities. It is being featured as part of a Disability Community Involvement initiative that reflects our commitment to Diversity, Inclusion,Corporate Citizenship and Social Responsibility.